恩瑞格怎么购买？

It is a drug that can help people with anemia symptoms. It is used for patients with iron accumulation due to long-term blood transfusion (such as thalassemia or other rare anemias). Enrig is suitable for children over two years old and adults. So, how to buy Enrig from Cipla in India?

Enrig has been included in medical insurance, but reimbursement rates vary from place to place, and long-term use is still relatively expensive. Enrig India’s Cipla Desirox 500mg*30 tablets are priced at about $240. Patients in need can purchase the drug abroad or obtain the drug through domestic professional overseas medical service organizations (such as Medical Companion Travel), and have it shipped directly to their homes, ensuring authenticity.

India's Cipla is the second largest pharmaceutical company in India, with strong financial and scientific research capabilities. Especially its cheap anti-AIDS and anti-cancer drugs are very popular among patients in developing countries. A generic drug is a copy of a brand-name drug that is identical in dosage, safety, potency (regardless of how it is taken), quality, effects, and indications. Enreg is one of these generic drugs.

Iron chelators are a new type of iron removal treatment based on directional binding of iron ions in the body, effectively increasing iron excretion, reducing iron content in the body and its pathological deposition in various organs. It is currently the only effective drug for the treatment of iron overload.

The application of iron chelators has greatly reduced the mortality rate and improved the quality of life of patients with long-term blood transfusions, and its clinical application has been receiving widespread attention and attention. Iron chelators currently used clinically mainly include deferoxamine (DFO), deferiprone (DFP), and Enrig.

Compared with deferoxamine, convenience is better and patient compliance is higher. The TELESTO study results released at ASH2018 also proved that deferasirox continuously reduces serum ferritin levels, while reducing the risk of heart function damage, liver function damage, transformation to leukemia and other events by 36.4%.